TG Therapeutics, Inc. (TGTX)
61.64
+0.89
(+1.47%)
USD |
NASDAQ |
Nov 04, 16:00
61.64
0.00 (0.00%)
After-Hours: 18:01
TG Therapeutics Total Return Price : 61.64 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 60.75 |
| November 02, 2026 | 59.95 |
| October 30, 2026 | 61.18 |
| October 29, 2026 | 58.08 |
| October 28, 2026 | 57.40 |
| October 27, 2026 | 56.44 |
| October 26, 2026 | 54.79 |
| October 23, 2026 | 54.17 |
| October 22, 2026 | 53.16 |
| October 21, 2026 | 53.20 |
| October 20, 2026 | 54.53 |
| October 19, 2026 | 53.30 |
| October 16, 2026 | 53.97 |
| October 15, 2026 | 56.00 |
| October 14, 2026 | 54.37 |
| October 13, 2026 | 54.34 |
| October 12, 2026 | 55.27 |
| October 09, 2026 | 55.37 |
| October 08, 2026 | 53.34 |
| October 07, 2026 | 52.95 |
| October 06, 2026 | 52.19 |
| October 05, 2026 | 53.91 |
| October 02, 2026 | 54.29 |
| October 01, 2026 | 53.62 |
| September 30, 2026 | 55.78 |
| Date | Value |
|---|---|
| September 29, 2026 | 56.19 |
| September 28, 2026 | 56.19 |
| September 25, 2026 | 57.43 |
| September 24, 2026 | 57.52 |
| September 23, 2026 | 56.00 |
| September 22, 2026 | 58.11 |
| September 21, 2026 | 57.16 |
| September 18, 2026 | 56.87 |
| September 17, 2026 | 56.47 |
| September 16, 2026 | 55.85 |
| September 15, 2026 | 53.04 |
| September 14, 2026 | 54.00 |
| September 11, 2026 | 53.89 |
| September 10, 2026 | 55.39 |
| September 09, 2026 | 54.65 |
| September 08, 2026 | 55.74 |
| September 04, 2026 | 55.98 |
| September 03, 2026 | 56.71 |
| September 02, 2026 | 56.90 |
| September 01, 2026 | 56.09 |
| August 31, 2026 | 54.30 |
| August 28, 2026 | 53.93 |
| August 27, 2026 | 55.72 |
| August 26, 2026 | 55.03 |
| August 25, 2026 | 55.42 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 549.06 |
| Krystal Biotech, Inc. | 310.87 |
| Regeneron Pharmaceuticals, Inc. | 930.74 |
| SELLAS Life Sciences Group, Inc. | 9.16 |
| Travere Therapeutics, Inc. | 52.42 |